MONDAY, Feb. 27, 2023 (HealthDay News) – Federal officials plan to tighten access to drugs that have the potential for abuse by reinstating federal prescribing requirements that were loosened during the pandemic. The Biden administration will require that patients see a doctor in person, rather than through a telehealth appointment,Continue Reading

THURSDAY, Feb. 23, 2023 (HealthDay News) — All those images of beautiful-looking people on social media can deflate a young person’s self-image, but there may be an easy fix: limiting time spent on TikTok, Instagram and the like. A new Canadian study finds that teens and young adults who alreadyContinue Reading

WEDNESDAY, Feb. 22, 2023 (HealthDay News) — If you’re one of the millions of people with a pacemaker or an implantable defibrillator to help control abnormal heart rhythms, certain health-tracking devices may do more harm than good. Smartwatches, rings or scales that emit electrical currents can interfere with these lifesavingContinue Reading

MONDAY, Feb. 20, 2023 (HealthDay News) — It’s a brutal reality that confronts many recovering stroke patients: After six months or so of rehab, any arm and hand movement not yet restored is unlikely to return. But new cutting-edge research aims to use electrical stimulation to jumpstart stroke-interrupted communication betweenContinue Reading

THURSDAY, Feb. 16, 2023 (HealthDay News) — Doctors could soon have a new tool to help diagnose chronic obstructive pulmonary disease (COPD). A questionnaire called CAPTURE successfully identified almost half of clinical trial participants who had moderate to severe forms of previously undiagnosed COPD, researchers report. “The goal with tryingContinue Reading

THURSDAY, Feb. 9, 2023 (HealthDay News) — Using a “neuroprotectant” drug alongside the standard surgical removal of a clot may slash the risk of death and disability following a stroke, a new study finds. The new medication, called ApTOLL, shields brain tissue from continuing damage by cooling down inflammation, theContinue Reading

THURSDAY, Feb. 9, 2023 (HealthDay News) — A single injection of an experimental biologic drug may cut in half your risk of hospitalization from COVID-19 infection, new clinical trial results show. Pegylated lambda interferon (PEG-lambda) proved effective against all COVID-19 variants encountered in this international study, including Omicron, according toContinue Reading